10:57 AM EST, 01/29/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.81% to 1,363.17 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and biopharmaceutical company argenx (ARGX), which rose 2.6% and 1.5% respectively. They were followed by software firm SAP (SAP) and energy company Equinor ( EQNR ) , which were up 1.4% and 1.3% respectively.

The decliners from continental Europe were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Genfit ( GNFT ) , which fell 5.2% and 2.8% respectively. They were followed by biopharmaceutical company Grifol (GRFS) and furniture maker Natuzzi (NTZ), which dropped 2.2% and 0.8% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana ( NCNA ) and Biodexa Pharmaceuticals ( BDRX ) , which increased 4.3% and 3% respectively. They were followed by biopharmaceutical companies TC Biopharm ( TCBP ) and Akari Therapeutics ( AKTX ) , which rose 2.4% and 2.3% respectively.

The decliners from the UK and Ireland were led by biotech company Trinity Biotech ( TRIB ) and biopharmaceutical company Amarin ( AMRN ) , which lost 6.4% and 3.9% respectively. They were followed by alcoholic beverage company Diageo ( DEO ) and pharmaceutical company Silence Therapeutics ( SLN ) , which were down 1.8% and 1.5% respectively.